About this Event
Join us onsite at The Midland Hotel Manchester
Overview
TIL (Tumour-Infiltrating Lymphocyte) therapy is a transformative, cell-based immunotherapy approach now entering clinical practice for melanoma. This national summit brings together UK and international leaders to share the science, clinical experience, and infrastructure required to implementTIL therapy safely and effectively. From the biological rationale to real-world delivery, the day explores how academic, clinical, and industry partners can work together to make TIL therapy accessible for patients across the UK
Intended Audience
Clinical Staff (including Clinical/ Medical Oncologists Surgeons, Haematologists, Pathologists, radiologists), Scientists, Translational Researchers, NHS Policymakers and those who have an interest in this field
What to expect
- Recognise how biomarkers and the tumour microenvironment predict TIL response
- Understand the core science and clinical development of TIL therapy
- Learn key factors in patient selection, team coordination, and toxicity management.
- Identify challenges in scaling TIL therapy across the NHS
Agenda
To be confirmed
Venue Information
We want everyone attending our event in person to have the best possible experience. We provide regular breaks, access to quiet spaces etc, but If there is anything else we can do to make the day/your experience more comfortable, please let us know by either completing this form, Inclusive learning support or emailing us: [email protected]
Please see our booking Terms and Conditions here
Click here to read our privacy policy: http://www.christie.nhs.uk/professionals/education/continuing-professional-development/study-days-and-conferences/school-of-oncology-events-privacy-policy/
Email [email protected] or call +44 (0) 161 918 7409
Event Venue & Nearby Stays
Midland Hotel, 16 Peter Street, Manchester, United Kingdom
GBP 25.00 to GBP 168.00
